Invention Grant
US07432280B2 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
失效
作为单胺摄取的抑制剂，3-氨基哌啶和3-氨基喹喔啉
- Patent Title: 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
- Patent Title (中): 作为单胺摄取的抑制剂，3-氨基哌啶和3-氨基喹喔啉
-
Application No.: US10558588Application Date: 2004-05-25
-
Publication No.: US07432280B2Publication Date: 2008-10-07
- Inventor: Christopher David Beadle , Manuel Javier Cases-Thomas , Barry Peter Clark , Peter Thaddeus Gallagher , John Joseph Masters , Graham Henry Timms , Magnus Wilhelm Walter , Maria Ann Whatton , Virginia Ann Wood , Jeremy Gilmore
- Applicant: Christopher David Beadle , Manuel Javier Cases-Thomas , Barry Peter Clark , Peter Thaddeus Gallagher , John Joseph Masters , Graham Henry Timms , Magnus Wilhelm Walter , Maria Ann Whatton , Virginia Ann Wood , Jeremy Gilmore
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Tonya L. Combs; Charles E. Cohen; Thomas E. Jackson
- Priority: GB0314414.4 20030620
- International Application: PCT/US2004/014529 WO 20040525
- International Announcement: WO2005/000305 WO 20050106
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A01N43/40 ; A61K31/44 ; A61K31/445 ; C07D453/02 ; C07D211/56 ; C07D211/98
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).
Public/Granted literature
- US20070066663A1 3-Aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake Public/Granted day:2007-03-22
Information query
IPC分类:
